Cargando…
High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
PURPOSE: To compare the outcome of our facility with another about the shortened schedule (60 Gy in 10 fractions to 54 Gy in 9 fractions) of high-dose-rate interstitial brachytherapy (HDR ISBT) for mobile tongue cancer. MATERIAL AND METHODS: Eighteen patients were treated with HDR ISBT as a monother...
Autores principales: | Akiyama, Hironori, Yoshida, Ken, Yamazaki, Hideya, Takenaka, Tadashi, Kotsuma, Tadayuki, Masui, Koji, Yoshioka, Yasuo, Arika, Takumi, Shimizutani, Kimishige, Tanaka, Eiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003422/ https://www.ncbi.nlm.nih.gov/pubmed/24790616 http://dx.doi.org/10.5114/jcb.2014.40726 |
Ejemplares similares
-
Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
por: Yoshida, Ken, et al.
Publicado: (2017) -
Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2014) -
A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2019) -
Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012) -
Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older
por: Yamazaki, Hideya, et al.
Publicado: (2010)